Trials / Completed
CompletedNCT00393835
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin Sustained Release (SR) For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis In Japan Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical efficacy and safety in patients with Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis receiving a dose of 2 g of azithromycin in the SR formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin SR |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2006-10-30
- Last updated
- 2008-05-16
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00393835. Inclusion in this directory is not an endorsement.